ArticleWorld journal of oncology2025

Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer.

Yoshimi Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.